Cargando…
The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Libbey Eurotext
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880647/ https://www.ncbi.nlm.nih.gov/pubmed/33270022 http://dx.doi.org/10.1684/ejd.2020.3775 |
| _version_ | 1783650738789941248 |
|---|---|
| author | Reinholz, Markus French, Lars E. Berking, Carola Heppt, Markus V. |
| author_facet | Reinholz, Markus French, Lars E. Berking, Carola Heppt, Markus V. |
| author_sort | Reinholz, Markus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7880647 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Libbey Eurotext |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78806472021-02-16 The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology Reinholz, Markus French, Lars E. Berking, Carola Heppt, Markus V. Eur J Dermatol Correspondence John Libbey Eurotext 2021-02-12 2020 /pmc/articles/PMC7880647/ /pubmed/33270022 http://dx.doi.org/10.1684/ejd.2020.3775 Text en © JLE/Springer 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Reinholz, Markus French, Lars E. Berking, Carola Heppt, Markus V. The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| title | The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| title_full | The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| title_fullStr | The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| title_full_unstemmed | The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| title_short | The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| title_sort | covid-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880647/ https://www.ncbi.nlm.nih.gov/pubmed/33270022 http://dx.doi.org/10.1684/ejd.2020.3775 |
| work_keys_str_mv | AT reinholzmarkus thecovid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT frenchlarse thecovid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT berkingcarola thecovid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT hepptmarkusv thecovid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT reinholzmarkus covid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT frenchlarse covid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT berkingcarola covid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology AT hepptmarkusv covid19pandemicimplicationsforpatientsundergoingimmunomodulatingorimmunosuppressivetreatmentsindermatology |